Skip to Main Content

Paper Details

Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer.
PLoS One
18
2015
EGFR, MAP-kinase, NCI-H1819 lung cancer cells, NKX2, NKX2-1, NKX2-1 amplified, NKX2-1 amplified NSCLC, NKX2-1 binding sites, NKX2-1 transcriptome, NKX2-1-amplified human NSCLC cell lines, NSCLC, Non-Small Cell Lung Cancer, PI3-kinase, binding sites, cancer, cancer cell, cell lines, cistrome, downstream transcriptional targets, epidermal growth factor receptor, erlotinib, homeobox transcription factor, human, lung cancer, non-small cell lung cancers, regulated genes
Author NameAffiliation
Jean M DavidsonStanford University School of Medicine
Jean M DavidsonStanford University School of Medicine
Jonathan R PollackStanford University School of Medicine
  • 1 - 3

Datasets

Release 1.2